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a b s t r a c t
Background: Outcome in ST-segment elevation myocardial infarction (STEMI) is affected by
patency of the infarct-related artery (IRA) on the initial angiogram. Therefore we decided to
assess the relation between patent IRA and time-dependent infarct transmurality.
Materials and methods: The study included 62 patients with ﬁrst STEMI (age 61  9 years,
76% male) undergoing primary percutaneous coronary intervention (PCI). All patients
underwent cardiovascular magnetic resonance (CMR) in the sub-acute phase to assess
infarct transmurality. Infarction was considered as transmural if mean infarct transmurality
exceeded >75%. IRA patency was deﬁned as TIMI ﬂow 2 or 3 on the initial angiogram.
Results: Patent IRA at baseline was found in 23 patients (37%) and was related to lower infarct
transmurality in comparison to IRA occlusion (46.9  27.3% vs. 82.4  21.3%, p < 0.0001).
Patients were divided into three groups according to time-to-PCI (2 h, >2–6 h, >6–12 h).
Infarct transmurality increased with increasing time-to-PCI in patients with occluded IRA on
the initial angiogram ( p = 0.0006), but not in patients with initially patent IRA ( p = 0.07).
Similarly, the frequency of transmural infarctions increased with longer time-to-PCI in
patients with occluded IRA ( p = 0.01), but not in patients with initially patent IRA ( p = 0.12).
Conclusions: Cardiovascular magnetic resonance demonstrated the relation between initial
IRA patency in STEMI and time-dependant infarct transmurality. After 6–12 h from the onset
of symptoms transmural infarctions were found in all patients with initially occluded IRA
and only in about a third of patients with initially patent IRA.
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The prognosis in ST-segment elevation myocardial infarction
(STEMI) is affected by initial patency of the infarct-related
artery (IRA) [1–3]. Patients who arrive in the cath-lab with
patent IRA are more likely to have successful primary
percutaneous coronary intervention (PCI), lower infarct size
and better survival in comparison to those with initially
occluded IRA [1–3].
Infarct transmurality and size in STEMI depend on the
time-to-reperfusion as demonstrated consequently by previ-
ous studies with the use of cardiovascular magnetic resonance
(CMR) [4–8]. Although this is true for all STEMI patients and for
patients who present with occluded IRA there are no sufﬁcient
data analyzing the same concept in patients with initially
patent IRA [8].
Therefore we decided to assess the relation between




The study group included 62 patients with ﬁrst STEMI (age 61
 9 years, 76% male) treated with primary PCI. All patients
received loading doses of 300 mg of aspirin and 600 mg of
clopidogrel in the pre-hospital phase (in the referring
hospital or in the ambulance) and unfractionated heparin
(in the pre-hospital phase or in the ambulance). None of the
patients received thrombolytics. Maintenance doses of
aspirin and clopidogrel were 75 mg daily. CMR examination
was performed in the sub-acute phase of AMI (days 3–5) in all
patients.
STEMI was deﬁned as (1) presence of continuous chest pain
for at least 30 min, (2) ST-segment elevation in 2 or more
contiguous ECG leads (1 mm for the arm leads and 2 mm for
precordial leads), (3) presence of coronary artery occlusion or
signiﬁcant coronary artery stenosis on the initial coronary
angiogram in the territory corresponding with ECG changes.
Each case of STEMI had to be eventually conﬁrmed with the
presence of elevated troponin I (TnI). The STEMI onset time
was obtained from the referral charts and was veriﬁed by the
patient. Time-to-PCI was deﬁned as time between the onset of
STEMI and balloon expansion (recorded from the procedure
timing chart). Patency of the IRA was based on the TIMI ﬂow
and deﬁned as TIMI ﬂow 2 or 3 [9].
All patients with contraindications to CMR in the sub-acute
phase of STEMI were excluded. These included: critical clinical
condition, acute or chronic renal failure deﬁned as estimated
glomerular ﬁltration rate <50 ml/min (value suggested by the
local ethics committee as a contraindication to gadolinium-
based contrast agents), severe form of claustrophobia and the
presence of temporary or permanent pacemakers or some
other metallic foreign objects in the body.
Informed consent was obtained from each participating
patient. The study was approved by the local ethics
committee.Cardiovascular magnetic resonance
CMR studies were performed with the use of 1.5 Tesla scanner
(Magnetom Avanto, Siemens, Erlangen, Germany). Scout
images and electrocardiographic gated breath-hold steady
state free precession (SSFP) cine images in 2- and 4-chamber
views were registered to set up ﬁnal short axis imaging planes.
Short-axis SSFP cine images were obtained from the mitral
valve insertion point to the apex with 8 mm thick slices and
2 mm gap between subsequent slices to encompass the entire
left ventricle (LV). The same short-axis and long-axis slice
positions were used to obtain dark-blood T2-weighted short-
tau inversion-recovery (STIR) fast-spin echo sequences.
Finally, a 0.1 mmol/kg of body weight of gadolinium contrast
(gadobutrol – Gadovist®, Bayer Schering Pharma AG, Berlin,
Germany) was administered via the antecubital vein and
ﬂushed with 30 ml of isotonic saline. Delayed enhancement
(DE) images were performed with a breath-hold segmented
inversion recovery sequence 10 min after contrast injection
and acquired in the same orientation as the cine images. The
inversion time was adjusted to completely null normal
myocardium.
Image analysis
Cine images were analyzed with the use of a dedicated
software (MASS 6.2.1, Medis, Leiden, the Netherlands).
Initially, short axis images were previewed from the base
to the apex in a cinematic mode, then endocardial and
epicardial contours for end-diastole and end-systole were
manually traced. Delineated contours were used for the
quantiﬁcation of end-diastolic and end-systolic volumes
normalized to body surface area (LVEDVI, LVESVI) and
ejection fraction (LVEF).
Intramyocardial hemorrhage was deﬁned as a hypoin-
tense zone within the area at risk deﬁned as myocardial tissue
with signal intensity of 2 standard deviations (SD) above
mean signal obtained in the remote myocardium on STIR
images [10]. Infarct size was deﬁned as area above 50% of the
maximal signal intensity within DE (full-width at half
maximum – FWHM) and expressed in grams (absolute infarct
size) and as a percentage of LV mass (relative infarct size) [11].
Mean infarct transmurality was calculated as a sum of infarct
transmurality in each segment divided by the number of
segments with subendocardial DE and presented as percent.
Infarction was labeled as transmural if mean infarct trans-
murality exceeded >75%. Microvascular obstruction (MVO)
was deﬁned as dark areas of absent contrast surrounded by
DE [12].
All images were analyzed by a single cardiologist with 6
years of training in CMR (ŁAM) and supervised by a senior
expert with 10 years of experience in CMR (JM).
Statistical analysis
All results for categorical variables were expressed as number
and percentage and for continuous variables as mean and
standard deviation (SD) or median and interquartile range
(IQR), depending on the normality of distribution assessed
with the use of a Kolmogorov–Smirnov test. Chi-square test or
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variables, when appropriate. Student's t-test or Mann–
Whitney test for unpaired samples was applied to compare
continuous variables depending on the normality of distribu-
tion. For comparisons between three groups of continuous
variables without normal distribution Kruskal–Wallis test
was computed. All tests were two-sided with a signiﬁcance
level of p < 0.05. Statistical analyses were performed with
MedCalc statistical software 10.0.2.0 (MedCalc, Mariakerke,
Belgium).
Results
Successful PCI (deﬁned as lack of residual stenosis and TIMI
ﬂow 3) was observed in 59 patients (95%). Three patients (5%)
had TIMI ﬂow 2 at the end of the procedure. All of those 3
patients presented with initial TIMI ﬂow 0.
Patients with and without initial IRA patency
Patent IRA at baseline was found in 23 patients (37%). There
were no differences in baseline characteristics between
patients with and without IRA patency except a trend toward
more frequent presence of proximal lesions in patients with
the occluded IRA (67% vs. 39%, p = 0.05) (Table 1). Initial IRATable 1 – Characteristics of patients with and without infarct-r
Parameter Occluded IRA
n = 39 (63%)
Age – yrs. (SD) 61.1 (11.2) 
Male sex – no. (%) 29 (74) 
Hypertension – no. (%) 22 (56) 
Hyperlipidemia – no. (%) 19 (49) 
Diabetes mellitus – no. (%) 6 (15) 
Current cigarette smoking – no. (%) 17 (44) 
Time-to-PCI 
2 h 5 (13) 
>2–6 h 21 (54) 
>6–12 h 13 (33) 
Infarct related artery – no. (%) 
LAD 22 (56) 
RCA 14 (36) 
Cx 3 (8) 
Lesion location in IRA – no. (%) 
Proximal 26 (67) 
Mid 10 (25) 
Distal 3 (8) 
Peak TnI – ng/ml (IQR) 81.0 (55.8–106.9
LVEDVI – ml/m2 (SD) 95.0 (21.6) 
LVEF – % (SD) 48.7 (9.2) 
Absolute infarct size – g (SD) 33.8 (16.3) 
Relative infarct size – % (SD) 22.8 (8.2) 
Mean infarct transmurality – % (SD) 82.4 (21.3) 
Transmural infarction – no. (%) 29 (74) 
MVO – no. (%) 31 (79) 
Intramyocardial
hemorrhage – no. (%)
22 (56) 
Cx, circumﬂex artery; IRA, infarct related artery; LAD, left anterior descend
left ventricular ejection fraction; MVO, microvascular obstruction; PCI, p
troponin I; RCA, right coronary artery.patency was related to smaller infarct size measured as peak
TnI and with means of the CMR (all p < 0.0001). Other
measures of larger infarct size such as the presence of
intramyocardial hemorrhage or MVO were also less frequently
found in patients with initial IRA patency (13% vs. 56%,
p = 0.001 and 35% vs. 79%, p = 0.0001, respectively).
IRA patency at baseline was related to lower mean infarct
transmurality in comparison to IRA occlusion (46.9  27.3% vs.
82.4  21.3%, p < 0.0001). As a consequence patients with
patent IRA on the initial angiogram were less likely to have a
transmural infarction (13% vs. 74%, p < 0.0001), they had a
higher LVEF (57.2  8.3% vs. 48.7  9.2%, p = 0.0006) and lower
LVEDVI (95.0  21.6 ml/m2 vs. 83.9  15.2 ml/m2, p = 0.035).
Seven of the 23 patients with initially patent IRA had TIMI
ﬂow 2. Additional analysis showed that patients with initial
TIMI ﬂow 2 had similar absolute infarct size (13.3 IQR 3.5–48.0 g
vs. 15.3 IQR 8.1–21.1 g, p = 0.55), relative infarct size (10.0% IQR
3.8–25.9% vs. 9.5% IQR 6.1–16.2%, p = 0.54) and median infarct
transmurality (62.5% IQR 0–90.6% vs. 45.8% IQR 25.0–62.2%,
p = 0.13) in comparison to those with initial TIMI ﬂow 3.
Time-to-PCI and infarct transmurality
Patients were divided into three groups according to time-to-
PCI (2 h, >2–6 h, >6–12 h). Mean infarct transmurality
increased with increasing time-to-PCI in all patients and inelated artery (IRA) patency on the initial angiogram.
Patent IRA





























ing artery; LVEDVI, left ventricular end-diastolic volume index; LVEF,
ercutaneous coronary intervention; peak TnI, peak concentration of
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and p = 0.0006) (Fig. 1A and B). On the contrary, in patients with
initially patent IRA there was only a trend toward increase in
means infarct transmurality with time (Fig. 1C).
Similarly, the frequency of transmural infarctions in-
creased with longer time-to-PCI, but only in the whole group
(0% for 2 h, 55% for >2–6 h, 75% for >6–12 h, p = 0.0001) and
in patients with occluded IRA (0% for 2 h, 76% for >2–6 h,Fig. 1 – Mean infarct transmurality (%) according to time-to-
PCI (=2 h, >2–6 h, >6–12 h) in all patients (A) and in patients
with occluded (B) and patent (C) infarct-related artery (IRA).
Central box represents the interquartile range (IQR). The
middle line represents the median. The horizontal line
extends from the minimum to the maximum value,
excluding ‘‘outside’’ and ‘‘far out’’ values which are
displayed as separate points.100% for >6–12 h, p = 0.01), but not in patients with initially
patent IRA (0% for 2 h, 10% for >2–6 h, 29% for >6–12 h,
p = 0.12).
Discussion
Myocardial salvage by reduction of time-to-reperfusion is a key
concept of the STEMI management according to the rule that
‘‘time is muscle’’ [13]. This has been conﬁrmed in modern
studies with non-invasive methods of infarct size assessment
as SPECT and CMR [3–8]. Recent analysis demonstrated that to
achieve signiﬁcant myocardial salvage reperfusion must occur
within the ﬁrst 3 h from the onset of symptoms [4]. Most of the
studies analyze patients with STEMI as a homogenous group,
despite the evidence that those who arrive in the cath-lab with
patent IRA have different prognosis [1–3]. Patency of the IRA
(TIMI 2/3) is related to better post-procedural perfusion, smaller
infarct size, higher LVEF, less frequent progression to heart
failure and lower mortality [1–3]. The smaller infarct size leading
to less extensive remodeling in patients with patent IRA (TIMI
ﬂow 2/3) in comparison to those with the occluded artery (TIMI
ﬂow 0/1) was also conﬁrmed in our study.
We have demonstrated that the group of STEMI patients is
not homogenous. The narrow time frame to infarct transmur-
ality is observed mainly in patients with initially occluded IRA
(TIMI ﬂow 0/1) in whom only reperfusion in the ﬁrst 2 h from
the onset of symptoms prevents development of transmural
necrosis. At the same time in patients with initially patent IRA
there is only a trend toward increase in transmurality of
myocardial infarction in time. This trend also demonstrates
that IRA may undergo reocclusion and reopening in time and
therefore supports the role of immediate primary PCI and
antiplatelet treatment in this group as in the whole population
of STEMI patients. Our results are similar to the ﬁndings of
Ortiz-Pérez et al. who demonstrated that infarct transmurality
increased in time in patients with poor residual ﬂow, but not in
patients with preserved residual ﬂow [8].
Our study has some limitations. First of all it included a
relatively small group of patients, however due to the costs of
CMR most other studies in that area were not performed on
much larger patient cohorts [5–8]. Inclusion of a larger group of
patients could have demonstrated that the time-dependent
increase of infarct transmurality is also signiﬁcant in patients
with initially patent IRA. Nevertheless this process seems
slower than in patients who present with occluded IRA.
Secondly, the infarct size analysis was performed only in the
sub-acute phase of STEMI and not after the end of the infarct
healing process. It was shown that the infarct zone undergoes
decrease during that time, which may be partially related to
resolution of tissue inﬂammation including myocardial edema
[14,15]. Therefore the ﬁnal infarct size may be lower, but only
by about 10–20%.
Conclusions
Cardiovascular magnetic resonance demonstrated the rela-
tion between initial IRA patency in STEMI and time-dependant
infarct transmurality. After 6–12 h from the onset of symptoms
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 3 7 – e 3 4 1 e341transmural infarctions were found in all patients with initially
occluded IRA and only in about a third of patients with initially
patent IRA.
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